Prescription drug · ANDA
Sunitinib Malate NDC 0378-6678
Sunitinib malate 12.5 mg/1 · Capsule · Oral · Mylan Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0378-6678-28 | 0037866782800378667828 | 28 CAPSULE in 1 BOTTLE, PLASTIC (0378-6678-28)Marketed from Jan 4, 2022 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sunitinib Malate
- Generic name (nonproprietary)
- sunitinib malate
- Active ingredients
- Sunitinib malate — 12.5 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Mylan Pharmaceuticals Inc.NDC labeler code 0378
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 201275
- Marketing start
- Listing expires
- Other FDA classes
- Protein Kinase Inhibitors (Mechanism)
- Identifiers
- Product ID 0378-6678_9e441770-fe62-43c0-b293-7ebc8f753ebcSPL ID 9e441770-fe62-43c0-b293-7ebc8f753ebcSPL set ID 4dbfcc02-dacc-4f0c-9f41-095783b68e27RxCUI 616279, 616285, 616289, 1541890UNII LVX8N1UT73
- Pharmacologic class
- Kinase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400378667828followed by a unit qualifier and the quantityPackage 00378-6678-28. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Sunitinib malate capsules are a kinase inhibitor indicated for: • treatment of adult patients with gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib mesylate. ( 1.1 ) • treatment of adult patients with advanced renal cell carcinoma (RCC). ( 1.2 ) • adjuvant treatment of adult patients at high risk of recurrent RCC following nephrectomy. ( 1.3 ) • treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in adult patients with unresectable locally advanced or metastatic disease. ( 1.4 ) 1.1 Gastrointestinal Stromal Tumor Sunitinib malate capsules are indicated for the treatment of adult patients with gastrointestinal stro…
Excerpt only. Read the full label for complete information.
About NDC 0378-6678
- What is NDC 0378-6678?
- 0378-6678 is the product NDC for Sunitinib Malate, Sunitinib malate 12.5 mg/1 capsule, listed with the FDA by Mylan Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Sunitinib Malate.
- What is the active ingredient?
- Sunitinib malate.
- Who is the labeler?
- Mylan Pharmaceuticals Inc., NDC labeler code 0378. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Sunitinib Malate?
- 31 other product NDCs are listed under this name. See all Sunitinib Malate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Sunitinib Malate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Sunitinib Malate | Sunitinib malate 12.5 mg/1 | CapsuleOral | Novadoz Pharmaceuticals LLC | 72205-116 | 72205-0116-28 |
| Sunitinib Malate | Sunitinib malate 25 mg/1 | CapsuleOral | Novadoz Pharmaceuticals LLC | 72205-117 | 72205-0117-28 |
| Sunitinib Malate | Sunitinib malate 37.5 mg/1 | CapsuleOral | Novadoz Pharmaceuticals LLC | 72205-118 | 72205-0118-28 |
| Sunitinib Malate | Sunitinib malate 50 mg/1 | CapsuleOral | Novadoz Pharmaceuticals LLC | 72205-119 | 72205-0119-28 |
| Sunitinib Malate | Sunitinib malate 12.5 mg/1 | CapsuleOral | Novugen Pharma (USA) LLC. | 82293-014 | 82293-0014-10 |
| Sunitinib Malate | Sunitinib malate 25 mg/1 | CapsuleOral | Novugen Pharma (USA) LLC. | 82293-015 | 82293-0015-10 |
| Sunitinib Malate | Sunitinib malate 37.5 mg/1 | CapsuleOral | Novugen Pharma (USA) LLC. | 82293-016 | 82293-0016-10 |
| Sunitinib Malate | Sunitinib malate 50 mg/1 | CapsuleOral | Novugen Pharma (USA) LLC. | 82293-017 | 82293-0017-10 |
| Sunitinib Malate | Sunitinib malate 12.5 mg/1 | CapsuleOral | Aurobindo Pharma Limited | 59651-464 | 59651-0464-2859651-0464-29 |
| Sunitinib Malate | Sunitinib malate 25 mg/1 | CapsuleOral | Aurobindo Pharma Limited | 59651-465 | 59651-0465-2859651-0465-29 |
Other NDCs under ANDA 201275
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Sunitinib Malate | Sunitinib malate 25 mg/1 | CapsuleOral | Mylan Pharmaceuticals Inc. | 0378-6679 |
| Sunitinib Malate | Sunitinib malate 50 mg/1 | CapsuleOral | Mylan Pharmaceuticals Inc. | 0378-6680 |
| Sunitinib Malate | Sunitinib malate 37.5 mg/1 | CapsuleOral | Mylan Pharmaceuticals Inc. | 0378-6681 |